These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10604242)

  • 1. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.
    Brown P; Cervenáková L; McShane LM; Barber P; Rubenstein R; Drohan WN
    Transfusion; 1999; 39(11-12):1169-78. PubMed ID: 10604242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.
    Brown P; Rohwer RG; Dunstan BC; MacAuley C; Gajdusek DC; Drohan WN
    Transfusion; 1998 Sep; 38(9):810-6. PubMed ID: 9738619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy.
    Cervenakova L; Yakovleva O; McKenzie C; Kolchinsky S; McShane L; Drohan WN; Brown P
    Transfusion; 2003 Dec; 43(12):1687-94. PubMed ID: 14641865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW; Head MW
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of blood-borne Creutzfeldt--Jakob disease.
    Brown P
    Dev Biol (Basel); 2000; 102():53-9. PubMed ID: 10794090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mononucleated Blood Cell Populations Display Different Abilities To Transmit Prion Disease by the Transfusion Route.
    Douet JY; Lacroux C; Litaise C; Lugan S; Corbière F; Arnold M; Simmons H; Aron N; Costes P; Tillier C; Cassard H; Andréoletti O
    J Virol; 2016 Jan; 90(7):3439-45. PubMed ID: 26764000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal prion protein, infectivity and neurofilament light-chain in blood of macaques with experimental variant Creutzfeldt-Jakob disease.
    Yakovleva O; Bett C; Pilant T; Asher DM; Gregori L
    J Gen Virol; 2022 Jul; 103(7):. PubMed ID: 35816369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant Creutzfeldt-Jakob disease and its transmission by blood.
    Ironside JW; Head MW
    J Thromb Haemost; 2003 Jul; 1(7):1479-86. PubMed ID: 12871283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy.
    Brown P
    Vox Sang; 2005 Aug; 89(2):63-70. PubMed ID: 16101685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood.
    Gregori L; Yang H; Anderson S
    Transfusion; 2011 Dec; 51(12):2596-602. PubMed ID: 21645006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.
    Gregori L; McCombie N; Palmer D; Birch P; Sowemimo-Coker SO; Giulivi A; Rohwer RG
    Lancet; 2004 Aug 7-13; 364(9433):529-31. PubMed ID: 15302197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creutzfeldt-Jakob disease: blood infectivity and screening tests.
    Brown P
    Semin Hematol; 2001 Oct; 38(4 Suppl 9):2-6. PubMed ID: 11685719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are prions transported by plasma exosomes?
    Cervenakova L; Saá P; Yakovleva O; Vasilyeva I; de Castro J; Brown P; Dodd R
    Transfus Apher Sci; 2016 Aug; 55(1):70-83. PubMed ID: 27499183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice.
    Yakovleva O; Janiak A; McKenzie C; McShane L; Brown P; Cervenakova L
    Transfusion; 2004 Dec; 44(12):1700-5. PubMed ID: 15584983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in screening test development for transmissible spongiform encephalopathies.
    Cervenakova L; Brown P
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):873-80. PubMed ID: 15566331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented?
    Vamvakas EC
    Transfus Med Rev; 2011 Apr; 25(2):133-44. PubMed ID: 21345641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins.
    Lee DC; Stenland CJ; Miller JL; Cai K; Ford EK; Gilligan KJ; Hartwell RC; Terry JC; Rubenstein R; Fournel M; Petteway SR
    Transfusion; 2001 Apr; 41(4):449-55. PubMed ID: 11316893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.